Sherri van Everen

Senior Vice President, Clinical Development at REGENXBIO

Sherri Van Everen has a diverse work experience. Sherri started their career as an Assistant Professor at Northeastern University's School of Pharmacy. Sherri then worked as an Outcomes Research Liaison at Eli Lilly before joining Genentech, where they held multiple positions including Health Economist and Principal Medical Science Liaison. After that, Sherri joined Avalanche Biotechnologies as an Executive Director of Scientific Collaborations. Sherri then moved on to REGENXBIO Inc., where they became the Vice President of Medical Affairs and later the Vice President of Ophthalmology Clinical Development. In addition to their industry experience, Sherri also served as a member of the Board of Directors for the Jack McGovern Coats Disease Foundation.

Sherri Van Everen completed their education at The University of Texas at Austin, where they earned a Doctor of Pharmacy (PharmD) degree in Pharmacy from 1995 to 1999. Prior to that, they attended Texas A&M University from 1990 to 1994, where they obtained a Bachelor of Science (BS) degree in Biomedical Science.

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


REGENXBIO

4 followers

REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.


Industries

Employees

201-500

Links